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Abstract
Background: Nuclear factor kB (NF-kB)-mediated pathways have been widely implicated in cell survival, development and
tumor progression. Although the molecular events of determining NF-kB translocation from cytoplasm to nucleus have
been extensively documented, the regulatory mechanisms of NF-kB activity inside the nucleus are still poorly understood.
Being a special member of macro domain proteins, LRP16 was previously identified as a coactivator of both estrogen
receptor and androgen receptor, and as an interactor of NF-kB coactivator UXT. Here, we investigated the regulatory role of
LRP16 on NF-kB activation.
Methodology: GST pull-down and coimmunoprecipitation (CoIP) assays assessed protein-protein interactions. The
functional activity of NF-kB was assessed by luciferase assays, changes in expression of its target genes, and its DNA binding
ability. Annexin V staining and flow cytometry analysis were used to evaluate cell apoptosis. Immunohistochemical staining
of LRP16 and enzyme-linked immunosorbent assay-based evaluation of active NF-kB were performed on primary human
gastric carcinoma samples.
Results: We demonstrate that LRP16 integrates into NF-kB transcriptional complex through associating with its p65
component. RNA interference knockdown of the endogenous LRP16 in cells leads to impaired NF-kB activity and
significantly attenuated NF-kB-dependent gene expression. Mechanistic analysis revealed that knockdown of LRP16 did not
affect tumor necrosis factor a (TNF-a)-induced nuclear translocation of NF-kB, but blunted the formation or stabilization of
functional NF-kB/p300/CREB-binding protein transcription complex in the nucleus. In addition, knockdown of LRP16 also
sensitizes cells to apoptosis induced by TNF-a. Finally, a positive link between LRP16 expression intensity in nuclei of tumor
cells and NF-kB activity was preliminarily established in human gastric carcinoma specimens.
Conclusions: Our findings not only indicate that LRP16 is a crucial regulator for NF-kB activation inside the nucleus, but also
suggest that LRP16 may be an important contributor to the aberrant activation of NF-kB in tumors.
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Introduction
Nuclear factor kB (NF-kB) is a dimeric transcription factor (p65–
p50) that is ubiquitously expressed and highly regulated [1].
Normally, it is localized in the cytoplasm as an inactive complex
through physical association with its inhibitor IkBa. A myriad of
endogenous and exogenous stimuli, such as tumor necrosis factor a
TNF-aand interleukin 1b IL-1b are capable of inducing the
activation of IkB kinase (IKK) complex, which then leads to the
ubiquitin-dependent degradation of IkBa. NF-kB is then free to
shuttle into the nucleus and to bind to specific sequences in the
promoter or enhancer regions of their target genes [2,3]. NF-kBh a s
a central role in the control of genes involved in cell survival,
immunity, inflammation, and development [3,4,5]. Aberrant
activation of NF-kB has been implicated in a variety of diseases,
such as atherosclerosis and diabetes [6]. The excessive or
constitutive activation of NF-kB is also frequently observed in
multiple tumors and this status is positively linked to poor prognosis
of those involved tumor patients [6,7]. To date, NF-kB and the
signalingpathways involved inits activation areconsidered themost
attractive targets for cancer prevention and therapy [8]. Several
IKK inhibiting compounds have been characterized as effective for
inhibiting NF-kB activity in cultured cancer cells and animal
models, and are likely to be safe for use in humans [9,10].
Although the molecular events that control the translocation of
NF-kB from the cytoplasmto the nucleus are well characterized [3],
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e18157knowledge concerning the regulation of NF-kB’s activity inside the
nucleus still remainslargely unknown. NF-kB is believed to recruit a
couple of cofactors to form a much higher order transcription
complex than onceexpected [2].Amongthewell-characterizedNF-
kB coactivators, p300/CREB-binding protein (CBP) appear to be
the basal components of functional NF-kB transcription complex
[11,12]. Some NF-kB coactivators such as poly(ADP-ribose)
polymerase-1 (PARP-1) and coactivator-associated arginine meth-
yltransferase (CARM1), in concert with p300/CBP, synergistically
coactivate NF-kB-mediated transcription [13,14].
The macro domain (130-190 amino acids) is a highly conserved
protein module found in all organisms [15], so named because it
was initially described as the non-histone region of the variant
histone macroH2A [16]. In vertebrates, macro domains are
frequently found in tandem with modules involved in ADP
ribosylation or the polymerization of poly(ADP-ribose) (PAR) as
well as ATP-dependent chromatin remodeling [15,17]. Although
structure analysis indicated that macro domain cannot directly
bind DNA [18], several macro domain proteins were found to be
able to access chromatin through sensing the activation of PARP-
1’s enzyme activity [19,20], and a few macro domain proteins
(only CoaSt6 and LRP16) were found to selectively bind to
chromatin with specific transcription factors and regulate their
transcriptional activities [21,22,23].
LRP16 can be regarded as a special member of the macro
domain superfamily because only a single stand-alone macro
module is harbored by it at its C-terminal region [17,23].
Biochemical characteristics analysis revealed that LRP16 can bind
withADP-ribosemetabolites includingboth mono(ADP-ribose) and
PAR by its macro domain module [24]. Similar with other macro
domain proteins, LRP16 can be recruited to the DNA damage sites
mediated by its biochemical capacity to bind PAR [20]. More
importantly, LRP16 has a specific function in that it acts as a
coactivator of both estrogen receptor a (ERa) and androgen
receptor (AR), as well as being their target gene [22,23,25].
UXT, a putative member of an a-class prefoldin protein family,
was reported to be able to interact with NF-kB and enhance its
transcriptional activity by the mechanism of maintaining the
presence of NF-kB inside the nucleus [26]. Independently, we
identified the physical interaction of LRP16 and UXT in vitro and
in vivo by a series of experiments [23]. On the basis of these
findings, we proposed that LRP16 may also regulate NF-kB
activity. To test this hypothesis, we used TNF-a-sensitive 293T
and HeLa cells to investigate the LRP16 regulation of TNF-a-
induced NF-kB activity. In this study, we provide evidence to show
that LRP16 integrates into the NF-kB transcriptional enhanceo-
some through associating with its p65 component and demon-
strated its crucial role for NF-kB activation inside the nucleus. In
addition, a positive link between the expression intensity of LRP16
in the nuclei and the NF-kB activity in human gastric carcinoma
specimens was preliminarily established. Placing these findings in
perspective, LRP16 may represent a therapeutic target in tumors
involving excessive NF-kB activity.
Results
LRP16 was identified as a novel interactor of NF-kB
subunit p65
Previously, we identified the physical interaction of LRP16 with
UXT [23], which had been reported to interact with several NF-kB
members including p65, p50 and c-Rel [26]. We proposed that
LRP16 may participate in the NF-kB transcriptional complex. To
validate this hypothesis, we assessed interactions among LRP16,
UXT, and NF-kB members using pull-down assays. As shown in
Figure 1A, p65 and UXT were both pulled down by GST-LRP16.
However, neither p50 nor c-Rel was pulled down by GST-LRP16
(Figure 1A). To further explore which region was necessary for p65-
LRP16 association, we used a series of p65 and LRP16 deletion
mutants in GST pull-down assays. The p65 fragments that spanned
amino acids 1–286, 1–312, and 1–372, but not the fragments that
spanned amino acids 285–551 and 307–551, were pulled down by
GST-LRP16 (Figure 1B). Full-length p65was pulled down by GST-
LRP16-C1, GST-LRP16-C2, and GST-LRP16-C3, but not by
GST-LRP16-N (Figure 1C). These results suggest that LRP16 can
interact with p65 in a cell-free system. Moreover, this interaction
appears to be mediated primarily by the macro domain of LRP16
and a specific region of the Rel homology domain (RHD) harboring
in p65 rather than in p50 and c-Rel.
To confirm that LRP16 can interact with p65 in cells, we
performed coimmunoprecipitation (CoIP) experiments using 293T
cells that had or had not beentreated with TNF-a. In the absence of
TNF-a stimulation, only a weak band that corresponded to
endogenous LRP16 in the complexes immunoprecipated with
anti-p65 antibody was detected. However, stronger bands were
detected during a time course of TNF-a treatment. Similarly,
reciprocal results were obtained by using anti-LRP16 antibody
(Figure 1D). Next, p65 was cotransfected with Flag-tagged LRP16,
LRP16N or LRP16C3, and CoIP assays were subsequently
performed using the antibodies indicated (Figure 1E). Consistent
withtheresultsfromthe GST pull-downassays(Figure1C),p65was
able to interact with the full-length LRP16 and LRP16C3, but not
LRP16N, in cells. Immunofluorescence analysis revealed that
LRP16 and p65 predominantly localized in the nucleus and
cytoplasm, respectively, in the absence of TNF-a treatment.
However, they colocalized in the nucleus when cellswerestimulated
with TNF-a (Figure S1A). These results suggest that LRP16 may
participate in the NF-kB transcriptional complex through associ-
ating with p65 after the nuclear translocation of NF-kB.
Overexpression of LRP16 does not significantly alter the
endogenous NF-kB activity
To investigate the functional significance of LRP16-p65
interaction, we used a kB-luc reporter gene initially to evaluate
the regulatory effect of LRP16 on the activation of NF-kB. The
results revealed that the ectopic expression of LRP16 increased
TNF-a- or IL-1b-induced kB-luc activity by more than 1.5 fold
(Figure 2A). Gene activation induced by p65 alone was also
increased in cells in which LRP16 was overexpressed (Figure 2B).
Similar results were observed in MCF-7 and HeLa cells (Figure
S2A).Inaddition,we alsofoundthat theGAL4BD-p65inductionof
GAL4-luc activity was further markedly enhanced by LRP16
(Figure S3). Next, several LRP16 mutants, including G182Y,
G270Y, and G182Y plus G270Y, which had been reported to
efficiently block the mono-ADP-ribose binding capacity of LRP16
[24], and LRP16N, LRP16C1, LRP16C2, and LRP16C3, were
compared with the wild-type LRP16. As expected, the LRP16N,
which did not associate with p65, failed to enhance reporter gene
activity relative to the empty vector control. Unexpectedly, all the
mutants with N-terminal deletion also failed to enhance the activity
of the reporter gene; however, the mutants G182Y, G270Y, and
G182Y plus G270Y augmented kB-luc activity after TNF-a
treatment to nearly the same extent as the full-length LRP16 did
(Figure 2C). These results suggest that the N- and C-terminal
portions of LRP16 are both required to coactivate NF-kB; however,
its capacity to bind mono(ADP-ribose) is not required.
An important biochemical characteristic of LRP16 is its ability
to senses PAR synthesis, which enables LRP16 to be recruited to
PARP-1 targeted DNA [20]. To determine whether the coactiva-
Activity Regulation of NF-kB by LRP16
PLoS ONE | www.plosone.org 2 March 2011 | Volume 6 | Issue 3 | e18157Figure 1. Physical interaction of LRP16 and p65. (A) GST and GST-LRP16 stained with Coomassie Blue are shown in the left panel.
[
35S]methionine-labeled UXT, p65, p50 or c-Rel was incubated with GST or GST-LRP16 as indicated in the middle and right panels. (B) The left panel
shows a schematic illustration of p65 and its mutants. GST pull-down assays were performed with various [
35S]-labeled mutants of p65 and GST-
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ability to senses PAR synthesis, we carried out luciferase assays
after we had added 3-aminobenzamide (3-AB), a potent enzyme
activity inhibitor of PARP-1, to the culture medium. As shown in
Figure 2D, we did not observe significant inhibition by 3-AB on
LRP16-enhanced reporter gene activity.
To test whether LRP16 had any measurable effects on inducible
genes that are regulated by NF-kB such as IkBa or A20 [27,28],
we performed qPCR experiments in 293T cells with or without
stable LRP16 transfection. As shown in Figure 3A, ectopic LRP16
expression in 293T cells only slightly increased the mRNA levels of
IkBa and A20 within 90 minutes after TNF-a treatment. We also
measured the mRNA levels of IkBa and A20 at 4- and 6-hours
after TNF-a treatment, but no significant difference was observed
between LRP16-transfected and mock-transfected cells. Next, we
analyzed the endogenous NF-kB DNA binding activity in 293T
cells with stable LRP16 transfection by performing electrophoretic
mobility shift assays (EMSA). As shown in Figure 3B, there was no
detectable NF-kB/DNA binding band in the absence of TNF-a
treatment. LRP16 overexpression did not also induce any
detectable basal NF-kB binding activity. In the presence of
TNF-a stimulation, robust NF-kB binding band was detected;
however, this band was not further strengthened by ectopic
expression of LRP16 in cells.
Knockdown of LRP16 not only attenuates NF-kB
transcriptional activity but also it’s DNA binding capacity
To further verify whether LRP16 is required for the
transcriptional activation of NF-kB, we examined the kB-luc
activity after LRP16 had been knocked down via RNAi.
Compared with the control siRNA, both siRNAs against LRP16
(374 and 668) caused a specific reduction of LRP16 expression at
both the mRNA and protein levels in 293T cells but did not affect
the expression of the p65, p50, and b-actin genes (Figure 4A).
Figure 2. Ectopic expression of LRP16 markedly upregulates cytokine-induced kB-luc activity. (A–D) 293T cells were cotransfected with
36kB-luc and the indicated vectors. Forty-two hours after transfection, cells were simulated with 10 ng/ml TNF-a or 20 ng/ml IL-1bfor 7 h before
luciferase assays were performed. The relative levels of luciferase activity were normalized to the activity obtained after cotransfection of 36kB-luc
and the empty expression vector, which was arbitrarily assigned a value of 1. All experiments were performed in triplicate and were repeated at least
three times, and the results are expressed as means6SD.
*P,0.05.
doi:10.1371/journal.pone.0018157.g002
LRP16 or GST alone (right panel). (C) The left panel shows a schematic illustration of LRP16 and its mutants. The middle panel shows GST, GST-LRP16
and its mutants stained with Coomassie Blue. GST pull-down assays were performed with [
35S]-labeled p65 and GST-LRP16 mutants or GST alone
(right panel). (D) 293T cells were treated with TNF-a (10 ng/ml) for the indicated times. Cell lysates were immunoprecipitated and immunoblotted
with the indicated antibodies. (E) 293T cells were cotransfected with p65 and Flag-tagged constructs. Forty-eight hours after transfection, cells were
lysed and the lysates subjected to CoIP using the indicated antibodies. The asterisk indicates a non-specific band. NsIgG: non-specific IgG.
doi:10.1371/journal.pone.0018157.g001
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gave better knockdown than 668 and therefore 374 was used more
frequently in later experiments. As shown in Figure 4B, knock-
down of the endogenous LRP16 dramatically inhibited TNF-a-
induced reporter gene activity. The activation of kB-luc induced
by p65 alone was also markedly attenuated in LRP16-deficient
293T cells (Figure 4C). Similar results were observed in HeLa and
MCF-7 cells (Figure S4). Ectopic expression of MyD88 and
TRAF6, which are well known to induce NF-kB activity [29,30],
did not effectively rescue TNF-a-stimulated kB-luc activities in
LRP16-knockdown 293T cells (Figure 4D).
We next investigated how the induction of NF-kB-dependent
genes was influenced by knocking down endogenous LRP16
expression. In this case, the induction of IkBa and A20 was
markedly attenuated (Figure 4E). In addition, the TNF-a
induction of several other NF-kB-dependent genes including
XIAP, cIAP1, cIAP2, FLIP, and IL8, but not NAIP and BIRC5, were
also markedly attenuated in LRP16-deficient 293T cells
(Figure 4F). Collectively, our data strongly indicate that the
expression of a certain level of LRP16 is necessary for the
induction of genes that are tightly regulated by NF-kB.
To further confirm whether LRP16 is required for the
activation of NF-kB, we analyzed the binding activity of NF-kB
with its cognate DNA sequence in LRP16-knockdown 293T
and HeLa cells by performing EMSA. Compared with that
from control-siRNA-transfected cells, the TNF-a-stimulated
DNA binding capacity of NF-kB was significantly diminished
in nuclear extracts from LRP16-specific knockdown cells
Figure 3. Ectopic expression of LRP16 does not significantly augment TNF-a-induced expression of the endogenous NF-kB target
genes and NF-kB DNA binding capacity. (A) 293T cells, which were stably transfected with the LRP16 expression construct or empty vector,
were treated with TNF-a (10 ng/ml) for the indicated times. Endogenous expression of IkBa and A20 mRNA was measured by qPCR. Data represent
means6SD (error bars) of at least three independent experiments. (B) 293T cells, which were stably transfected with the LRP16 expression or empty
vector, were treated with TNF-a (10 ng/ml) for the indicated times, lysed and the nuclear extracts subjected to EMSA assays. Sp1 was used as a
loading control.
doi:10.1371/journal.pone.0018157.g003
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correlated with the effectiveness of the siRNAs administered.
To substantiate this finding, we took advantage of chromatin
immunoprecipitation (ChIP) assays to test whether the binding of
NF-kB to its endogenous promoter was influenced in LRP16-
knockdowncells.AsshowninFigure5B,TNF-anot onlystimulated
a remarkable recruitment of p65, p50 and RNA polymerase II, but
also LRP16 on both A20 and IkBa promoters in control-siRNA
transfected cells, strongly indicating that LRP16 is a component of
NF-kB enhanceosome. However, knockdown of the endogenous
LRP16 led to a considerable decrease in the amount of p65
associated with its cognate promoters. In addition, the amount of
Figure 4. Knockdown of LRP16 markedly attenuates NF-kB transcriptional activity. (A) 293T cells were transfected with the indicated
siRNAs. Forty-eight hours after transfection, the endogenous expression of LRP16 mRNA was monitored by RT-PCR, and the protein levels of LRP16,
p65, and p50 were determined by immunoblotting. b-actin was used as a loading control. (B–D) 293T cells were cotransfected with 36kB-luc, siRNA
and vectors as indicated. Forty-two hours after transfection, cells were stimulated with 10 ng/ml TNF-a for 7 h and then luciferase assays were
performed. The relative levels of luciferase activity were normalized to the activity obtained after cotransfection of 36kB-luc and the empty
expression vector, which was arbitrarily assigned a value of 1. All experiments were performed in triplicate and were repeated at least three times,
and the results are expressed as means6SD. (E) 293T cells were transfected with the indicated siRNAs. Forty-eight hours after transfection, cells were
stimulated with 10 ng/ml TNF-a for the indicated times. Endogenous expression of the indicated genes was measured by qPCR. Data represent
means6SD (error bars) of at least three independent experiments. (F) 293T cells were treated as in (E), cells were stimulated with 10 ng/ml TNF-a for
90 min. Endogenous expression of the indicated genes was measured by qPCR. Data represent means6SD (error bars) of at least three independent
experiments. *P,0.05, **P ,0.01,
N P.0.05.
doi:10.1371/journal.pone.0018157.g004
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was also dramatically decreased in LRP16-deficient cells. As a
negative control, knockdown of LRP16 had no effect on the
GAPDH transcriptional complex. These finding indicate that
LRP16 is an essential component of NF-kB enhanceosome.
Knockdown of LRP16 blunts the interaction of NF-kB
with p300/CBP/CARM1 in nuclei
The activation of NF-kB involves a series of molecular events
in the cytoplasm and in the nucleus [3]. To rule out the possibility
that LRP16 might act on the TNF-a-induced nuclear transloca-
tion of NF-kB, we examined the effects of LRP16 knockdown on
IKK activity and the expression of IkBa protein induced by
TNF-a over time. The results showed that the siRNAs targeting
LRP16 did not affect TNF-a-induced IKK activities (Figure
S5A). In addition, IkBa level in 293T cells was rapidly and
transiently reduced upon TNF-a stimulation, whether or not the
endogenous LRP16 had been inhibited (Figure S5B). By
immunofluorescence analyses, we did not observe marked
difference for the nuclear translocation of p65 between the
LRP16-deficient and mock-transfected cells upon TNF-a stimu-
lation (Figure S1B and S1C). These results demonstrate that
LRP16 performed its function via targeting NF-kB itself in the
nucleus, but not via affecting IkBa degradation and NF-kB
nuclear translocation. This conclusion was further authenticated
by measuring the amount of p65 in nuclei after TNF-a treatment
(Figure S5C).
Due to the lack of domains in LRP16 that are found in
conventional transcriptional coregulators, we speculated that
LRP16 may execute its coactivation effect on NF-kB by affecting
the assembly or stability of the NF-kB transcriptional complex in
nucleus. To validate this hypothesis, we analyzed the interactions
Figure 5. Knockdown of LRP16 sharply attenuates the DNA binding capacity of NF-kB. (A) 293T or HeLa cells were transfected with the
indicated siRNAs. Forty-eight hours after transfection, cells were stimulated with 10 ng/ml TNF-a for the indicated times, lysed and the nuclear
extracts subjected to EMSA assays. Sp1 was used as a loading control. (B) 293T cells were treated as in (A). The ChIP assays were performed for the
A20, IkBa and GAPDH promoters using the indicated antibodies and corresponding primers described in Materials and Methods.
doi:10.1371/journal.pone.0018157.g005
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p300, CBP, and CARM-1, by performing CoIP experiments. As
shown in Figure 6A, by using p65/p50 interaction as a control, we
observed that the association of p65 with these coactivators in the
presence of TNF-a was considerably reduced in LRP16-
knockdown cells. In addition, we also observed the decreased
recruitment of p300/CBP on the promoters of both A20 and IkBa
in LRP16-knockdown cells (Figure 6B). These results demonstrate
that knockdown of LRP16 blunts the interactions of NF-kB with
other essential coactivatiors such as p300/CBP.
Knockdown of LRP16 sensitizes TNF-a-induced cell
apoptosis
Activation of NF-kB can prevent cell apoptosis induced by
TNF-a by promoting the expression of several antiapoptotic genes.
A low concentration of cycloheximide (CHX, ,10 mg/ml), which
is a potent inhibitor of protein synthesis, can dramatically augment
TNF-a-induced apoptosis effect [31]. Based on the above-
mentioned findings that LRP16 is required for NF-kB activation,
we further explored whether TNF-a-induced cell apoptosis is
modulated by LRP16 by using TNF-a-sensitive 293T and HeLa
cells. The apoptotic rate of both 293T and HeLa cells after
treatment with TNF-a plus CHX was not markedly increased by
stably transfecting LRP16 or its mutants into these cells (Figure
S6). However, when the endogenous LRP16 was inhibited by
siRNAs, apoptotic bodies and other dramatic morphological
changes indicative of cells undergoing apoptosis were observed
under microscope (Figure 7A and S7). Changes of apoptotic
percentage quantitatively evaluated by annexin V staining and
FASC analysis also revealed that knockdown of LRP16 expression
significantly augmented cell apoptosis induced by TNF-a plus
CHX (Figure 7B). Similar results were observed in HeLa cells
(data not shown). Moreover, we observed that TNF-a-induced
upregulation of antiapoptotic protein XIAP and FLIP was
efficiently blocked by inhibiting LRP16 expression in 293T cells
(Figure 7C).
Figure 6. Knockdown of LRP16 impairs the formation or stability of NF-kB/p300/CBP/CARM1 complex inside the nucleus. (A) 293T
cells were transfected with the indicated siRNAs. Forty-eight hours after transfection, cells were treated with 10 ng/ml TNF-a for the indicated times
and the nuclear fraction was purified. Equal amounts of nuclear lysates were immunoprecipitated and immunoblotted with the indicated antibodies.
(B) 293T cells were treated as in (A), ChIP assays were performed for the A20, IkBa and GAPDH promoters using the indicated antibodies and
corresponding primers described in Materials and Methods.
doi:10.1371/journal.pone.0018157.g006
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correlated with elevated NF-kB activity in gastric
carcinoma samples
Our previous studies revealed that LRP16 can interact with
both ERa and AR [22,23]. In this study, we determined that
LRP16 can also associate with the NF-kB transcriptional complex.
To clearly determine whether LRP16 expression could be
extended to NF-kB activity in clinical samples, human gastric
carcinoma specimens were selected, instead of hormone related
cancers, in order to exclude the possible competitive interaction
interference of LRP16 with other transcription factors, such as
ERa and AR. Samples from 66 cases of human gastric carcinoma
were initially subject to immunoblotting analysis of total LRP16
protein amount and enzyme-linked immunosorbent assay
(ELISA)-based evaluation of active NF-kB. However, this assay
did not significantly link the LRP16 expression level with NF-kB
activity (data not shown). Then, we turned to perform immuno-
Figure 7. Knockdown of LRP16 sensitizes TNF-a-induced cell apoptosis. (A) 293T cells were transfected with the indicated siRNAs. Forty-
eight hours later, cells were treated with TNF-a plus CHX or left untreated for 22 h. Representative microscopic images are shown (right panel for
DAPI staining). Bar=20 mm. (B) 293T cells were treated as in (A), the percentage of apoptotic cells was monitored by annexin V staining followed by
FACS analysis. Experiments to analyze apoptosis were performed in triplicate and were repeated at least three times, and the results are expressed as
means6SD. (C) 293T cells were transfected with the indicated siRNAs. Forty-eight hours after transfection, cells were stimulated with 10 ng/ml TNF-a
for an additional 12 h. Total protein was prepared and immunoblotting was performed with the indicated antibodies.
doi:10.1371/journal.pone.0018157.g007
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graphs from three selected cases are presented in Figure 8A.
Negative nuclear (left panel) and prominent cytoplasmic staining
(middle panel) of LRP16 were defined as negative, and prominent
nuclear staining (right panel) was defined as positive, as described
previously [32]. Under these criteria, 32 and 34 cases were
classified as LRP16 negative and LRP16 positive, respectively.
The level of active NF-kB in the LRP16-positive subset (OD
value=0.31660.042) was significantly higher than that in the
LRP16-negative subset (OD value=0.28860.036) (t=31.64;
P=0.012) (Figure 8B). The correlation between activity of NF-
kB and LRP16 expression was statistically significant for these two
patient subsets (r=0.326; P=0.014). These data suggest that the
prominent nuclear distribution of LRP16 may be positively
correlated with the increased NF-kB activity in human gastric
carcinomas and further support the notion that LRP16 is a critical
regulator for NF-kB activation inside the nucleus.
Discussion
In this study, the macro domain protein LRP16 was identified
as a novel interactor of NF-kB component p65. By a series of
independent approaches, we demonstrated that LRP16 partici-
pates in the NF-kB enhanceosome and is crucial for the
recruitment of NF-kB for essential coactivators such as p300 and
CBP. Knockdown of LRP16 led to impaired NF-kB activity and
signaling output. The regulatory role of LRP16 on NF-kB activity
was further corroborated by a positive relationship between the
staining intensity of LRP16 in the nuclei of tumor cells and the
level of NF-kB activity in human gastric carcinomas. These
findings highlight an important nuclear function of LRP16 in the
regulation of NF-kB transcriptional activity and suggest that
LRP16 might be an important contributor to elevated NF-kB
activity in tumors.
The biochemical feature of binding PAR is required for macro
domain proteins including LRP16 to participate into PARP-1-
based complex in response to DNA damage [19,20]. In this study,
the luciferase results as shown in Figure 2C and 2D did not
demonstrate the link between the LRP16 coactivation of TNF-a-
induced NF-kB transcriptional activity and its biochemical feature
of binding ADP-ribose metabolites. These results suggest that the
biochemical activity of binding ADP-ribose metabolites is
dispensable for macro domain proteins when they serve as
transcriptional cofactors.
By knockdown assays, we demonstrated that LRP16 is essential
for NF-kB activation. In addition, this interference also sensitizes
TNF-a-induced cell apoptosis. Although we also demonstrated
that the ectopic expression of LRP16 can significantly increase
TNF-a-induced kB-luc activity, this ectopic expression in 293T
cells did not further enhance TNF-a-induced NF-kB-dependent
gene expression, and its DNA binding ability. These results
indicate that the endogenous amount of LRP16 inside the nuclei
of some cell types is in a saturate status for maximally activating
the endogenous NF-kB activity. However, exogenous LRP16 is
required for maximally activate the exogenous kB-luc activity.
Figure 8. The expression level of LRP16 in nuclei is positively associated with the elevated NF-kB activity in human gastric
carcinoma specimens. (A) Immunostaining of LRP16 in three representative gastric carcinoma samples. LRP16 is stained dark brown; nuclei were
counterstained with hematoxylin (light blue). The left panel shows no staining. Predominant cytoplasmic staining of LRP16 is shown in the middle
panel. The right panel shows predominant nuclear staining of LRP16. Bar=20 mm. (B) The DNA binding activity of NF-kB in the LRP16 negative and
positive groups was measured by using an ELISA-based chemiluminescent kit as described in Materials and Methods.
doi:10.1371/journal.pone.0018157.g008
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transcription factors, but the differential requirement for shared
coactivators may occur in these cases [33,34]. In addition to NF-
kB, LRP16 can interact with some steroid receptors such as ERa
and AR, and is essential for their transactivation [22,23]. The
macro domain alone of LRP16 is enough to mediate its interaction
with both p65 and AR. The macro domain alone can augment
AR-dependent gene transcription in the same way as the wild type
protein [23]; however, the macro domain and the non-macro
domain regions of LRP16 are both required to activate NF-kB-
dependent transcription activity.
Although regulatory events in the nucleus all shape the strength
and duration of the NF-kB transcriptional response, the different
factors recruited by NF-kB posses differential action mechanisms.
p300/CBP was found to associate directly with NF-kB and form a
bridge between NF-kB and the basal transcriptional machinery
[11,12]. CARM-1 synergistically coactivates NF-kB-mediated
transcription in a promoter-dependent manner, in concert with
p300/CBP and p160 [13]. In this study, we demonstrated that the
nuclear translocation of NF-kB in the presence of TNF-a
stimulation was not affected by LRP16 knockdown. However,
the formation or stability of NF-kB transcription complex (NF-
kB/p300/CBP/CARM1) was markedly impaired in nuclei of
LRP16-deficient cells. Our findings support the notion that
LRP16 is essential for the assembly or stability of the functional
NF-kB transcription complex in the nucleus. The precise
mechanism regarding how LRP16 affects the formation of
functional NF-kB complex still remains to be studied and is an
interesting and important subject of further investigation.
NF-kB-associated pathways have been widely implicated in
oncogenesis and tumor progression by stimulating cell prolifera-
tion, inhibiting apoptosis, and promoting metastasis and angio-
genesis [35]. Aberrant activation of NF-kB is frequently observed
in several tumor types including gastric carcinomas [36,37,38]. In
this study, a positive link between the prominent staining of
LRP16 inside the nucleus and the elevated NF-kB activity was
established in gastric carcinoma specimens. In view of the fact that
the clinicopathological data we obtained previously from a large
number of samples, which included breast cancer, gastric cancer
and colorectal carcinoma, indicated that predominant nuclear
staining of LRP16 in tumor cells is significantly linked to high-risk
prognostic indices and short survival term [32,39,40], we proposed
that the aberrant nuclear accumulation of LRP16 would be a
common mechanism employed by tumor cells by which NF-kB
was excessively activated. The predominant nuclear staining of
LRP16 in tumor cells may be a valuable indicator for the
evaluation of excessive NF-kB activity.
Aberrant stimulation of estrogen and androgen plays a central
role in the genesis and progression of breast cancer and prostate
cancer, respectively [41,42]. Crosstalk or reciprocal regulation
between hormone-dependent pathways, including ERa- and AR-
mediated signal transduction, and NF-kB signaling has been
extensively established at multiple signaling nodes [43,44,45].
However, reasonable explanations for excessive NF-kB activity in
hormone-dependent cancers remain to be investigated [46,47,48].
Previously, we demonstrated that estrogen can upregulate LRP16
expression in estrogen-dependent breast cancer, endometrial
cancer, and ovary cancer cell lines [22,25,49,50,51,52]. Androgen
can also upregulate LRP16 expression in androgen-sensitive
prostate cancer cell lines [23]. The expression level of LRP16 in
hormone-dependent cancer cell lines is dependent on hormone
action. In addition, we also previously revealed the promotion of
LRP16 to proliferation or invasive growth of hormone-dependent
cells [22,23,25,51]. The identification of the hormone-responsive
gene LRP16 acting as an crucial coactivator of NF-kB in this study
may provide a novel clue for linking hormone-dependent signaling
and NF-kB activity in hormone-dependent cancers.
In conclusion, these findings provide definite evidence to
support the integration of the macro domain protein LRP16 into
the NF-kB transcriptional complex via interaction with p65 and its
crucial role for NF-kB activation inside the nucleus. Aberrant
nuclear accumulation of LRP16 in tumor cells might represent a
therapeutic target for the control of excessive NF-kB activity.
Materials and Methods
Reagents
The LRP16-specific siRNAs 374 and 668 and the control
siRNA were chemically synthesized by GenChem Co., Ltd
(Shanghai, China). TNF-a and IL-1b were purchased from
R&D systems. Lipofectamine 2000 was purchased from Invitro-
gen. SuperFect transfection reagent was obtained from QIAGEN.
Antibodies against p65, p50, IkBa, FLIP, CARM1, Sp1, and b-
actin were purchased from Santa Cruz Biotechnology. Antibodies
against p300/CBP and CARM1 were purchased from Bioworld
Technology Co., Ltd. The antibody against XIAP was purchased
from Marine Biological Laboratory. The LRP16 antibody was
described previously [23]. 3-aminobenzamide (3-AB), cyclohexi-
mide (CHX) and the antibody against FLAG tag and RNA
polymerase II were obtained from Sigma-Aldrich.
Plasmids
The LRP16 and UXT constructs were described in our
previous reports [23]. The expression vectors for p50, c-Rel, p65
and its mutants, TRAF6, and MyD88, and the luciferase reporter
36kB-luc, were kindly donated by Professor Chen Wang (Chinese
Academy of Science). The mutants of LRP16, including G182Y,
G270Y, and G182Y plus G270Y, were provided by Dr. Tero
Ahola (Institute of Biotechnology, University of Helsinki). GAL4-
luc was prepared by cloning five GAL4 binding sites into the pGL-
Basic vector (Promega). The plasmid encoding GAL4BD-p65 was
constructed by cloning p65 in-frame with amino acids 1-147 of the
GAL4 protein in a pcDNA3.1 (Invitrogen) backbone.
Human samples
Studies using human tissues were approved by the Institutional
Ethical Committee in Chinese PLA General Hospital. Tissues
samples of gastric carcinomas were collected from 66 patients who
had undergone subtotal gastrectomy in the Chinese PLA General
Hospital from August to December in 2009 following written
informed consent. The cancerous tissue samples were immediately
frozen into liquid nitrogen or fixed in 10% formalin for subsequent
analysis. Sixty-six patients were classified into the following groups
according to their pathological diagnoses: well-moderately differ-
entiated adenocarcinoma (N=20), mucinous adenocarcinoma
(N=7), poorly differentiated adenocarcinoma (N=28), signet-ring
cell carcinoma (N=7), and other gastric carcinoma (N=4).
Cell culture, transfection and preparation of nuclear
extracts
293T and HeLa cells were obtained originally from the
American Type Culture Collection (ATCC, Rockville, MD,
USA) and cultured according to the instructions provided.
SuperFect reagent was used for DNA transfection, whereas
Lipofectamine 2000 was used to transfect cells with siRNA
duplexes. Total or nuclear proteins were extracted using a
ReadyPrep
TM protein extraction kit (Bio-Rad Laboratories).
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assays
GST and GST fusion proteins were prepared as described
previously [23,53].
35S-labeled proteins were produced by using a
TNT-coupled in vitro transcription and translation (IVT) system
(Promega), with the expression vectors for p65 and its derivatives,
p50 and c-Rel in pcDNA3 or pcDNA3.1. GST pull-down assays
were performed primarily as described previously [23,53].
Coimmunoprecipitation (CoIP) and immunoblotting
Cells were cultured in 10-cm dishes, transfected with expression
vectors or siRNA duplexes or mock transfected, and then were
treated with TNF-a for the indicated times. The cells were then
harvested and total protein or nuclear proteins were extracted.
The CoIP and immunoblotting were performed as described
previously [23,53].
Luciferase assays
Cells were seeded in 35-mm culture dishes and were
cotransfected with 0.5 mgo fkB-luc or GAL4-luc reporter
construct and other constructs as indicated, or 1 mg of siRNA
duplexes. pRL-SV40 (1 ng) was used as an internal control. The
total amount of nucleotide was kept constant by supplementing
with pcDNA3. Fourty-two hours later, the cells were treated with
the reagents indicated or left untreated. Luciferase activity was
analyzed with the Dual-Luciferase Reporter Assay System
(Promega) as described previously [23,53].
IKK activity analyses
293T cells that had been transfected with the indicated siRNAs
were treated with TNF-a (10 ng/ml) or left untreated for 15 min.
IKK kinase assays were performed with the IKKa/b assay/
Inhibitor Screening Kit (Abnova), in accordance with the
manufacturer’s instructions.
Immunofluorescence and microscope
Cells grown on coverslips were fixed with 4% paraformalde-
hyde, permeabilized in 0.5% TritonX-100, blocked with 10% goat
serum, and stained with either mouse-anti LRP16 or rabbit-anti
p65 antibodies followed by fluorescein isothiocyanate (FITC)-
conjugated goat anti-mouse IgG (Santa Cruz) or Alexa-Fluor 594-
conjugated goat anti-rabbit IgG (Invitrogen). Nuclei were
counterstained with DAPI. Immunofluorescence analysis was
performed using a Nikon fluorescence microscope equipped with
the appropriate filters for three-color imaging of cells and with a
CDD camera.
Quantitative RT-PCR (qPCR)
Total RNA was isolated using TRIzol Reagent (Invitrogen).
cDNA was prepared using PrimeScript
TM reverse transcriptase
(Takara Shuzo Co., Tokyo, Japan) and 1 to 2 mg of total RNA.
cDNA was subjected to qPCR using the SYBR Green PCR
Reagents Kit (Bio-Rad). PCR primers were as follows: LRP16
sense, 59-CCGCAGCGACATCACCAAGC-39, antisense 59-TC-
CGGCACTCGTCGGTAAGC-39. A20 sense 59-CCTGCTGG-
CTGCCTGTCT-39, antisense, 59-GAACCTGGACGCTGT-
GGG-39; IkBa sense, 59-GAGGAAATACCCCCCTACACC-39,
antisense 59-AGCACCCAAGGACACCAAAAG-39; IL8 sense,
59-ACTCCAAACCTTTCCACC-39, antisense 59-AAACTTCT-
CCACAACCCTC-39; cIAP1 sense, 59-TCCAGTTCAGCCT-
GAGCAGC-39, antisense 59-TCCCAACACCTCAAGCCACC-
39; cIAP2 sense, 59-TTTTGCTGTGATGGTGGACTC-39, antisense
59-TCTCCTGGGCTGTCTGATGTG-39; XIAP sense, 59-CTTCCAA-
GAAATCCATCCA-39, antisense, 59-TTCCAATCAGTTAGCCCT-
C-39; FLIP sense, 59-CTCACCTTGTTTCGGACT-39, antisense, 59-
CCTTGCTTATCTTGCCTC-39; NAIP sense, 59-TTTGAATGATGA-
CAGCGTG-39, antisense, 59-CTGTGAAATGCCTGGAGAT-39; BIR-
C5 sense, 59-CCAGACTTGGCCCAGTGTTTC-39, antisense 59-AC-
TTTCTCCGCAGTTTCCTCA-39; HPRT sense, 59-TTGCTCGA-
GATGTGATGAAAGGA-39; antisense, 59-TTCCAGTTAAAGTTGA-
GAGATCA-39. Reactions were run on a LightCycler (Roche).
Electrophoretic mobility shift assay (EMSA)
EMSA was carried out essentially as described previously
[50,53]. Wide-type kB probe and Sp1 probe were labeled with T4
polynucleotide kinase and [c-
32P]dATP. For each 25 ml reaction,
10 mg nuclear extracts were incubated with
32P-labeled probes in
binding buffer for 20 minutes at room temperature. A 100-fold
excess of unlabeled wild-type or kB mutant oligonucleotide was
used for competition experiments. An amount of 6 mg of anti-p65
or non-specific IgG was used for supershift experiment. The
sample was run through a 6% polyacrylamide gel then dried and
subjected to autoradiography. The following probes were used:
wild-type kB probe (AGTTGAGGGGACTTTCCCAGGC),
mutant kB probe (AGTTGAGGCGACTTTCCCAGGC), and
Sp1 probe (-ATTCGATCGGGGCGGGGCGAGC).
Chromatin immunoprecipitation (ChIP) assay
The ChIP assays were carried out essentially as described
previously [49,50]. 293T cells were transfected with the indicated
siRNAs (control, 668 and 374). Forty-eight hours later, cells were
treated with TNF-a (10 ng/ml) for 60 minutes, then ChIP assays
were performed using Chromatin Immunoprecipitation Assay Kit
(Millipore Corporation, MA, USA) according to the manufactur-
er’s instructions. The following antibodies were used: anti-LRP16,
anti-p65, anti-p50, anti-polymerase II, anti-p300, anti-CBP, and
non-specific IgG. DNA fragment were purified with use of a PCR
Production Purification Kit (Qiagen). The presence of the target
DNA fragments in both the input and the recovered DNA
immunocomplexes was detected by PCR. The following primers
were used: A20 promoter sense (59-CAGCCCGACCCAGA-
GAGTCAC-39) and antisense (59-CGGGCTCCAAGCTCG-
CTT-39); IkBa promoter sense (59-TAGTGGCTCATCGCAGG-
GAG-39) and antisense (59-TCAGGCTCGGGGAATTTCC-39);
GAPDH promoter sense (59-AGCTCAGGCCTCAAGACCTT-
39) and antisense (59-AAGAAGATGCGGCTGACTGT-39).
Apoptosis assays
Cells that had been transfected stably with LRP16 or LRP16
mutants or transiently with the indicated siRNA were treated with
TNF-a (293T, 50 ng/ml; HeLa, 5 ng/ml) and CHX (5 mg/ml) or
left untreated for 22 h. Floating and adherent cells were collected
and analyzed using the Annexin V-FITC Apoptosis Detection Kit
I (BD Bioscience, CA, USA) in accordance with the manufactur-
er’s instructions. A FACSCalibur flow cytometer (BD Biosciences)
was used.
ELISA-based DNA binding assay for NF-kB p65, and
immunohistochemistry (IHC)
The DNA binding activity of NF-kB in the tumor samples was
measured by using the enzyme-linked immunosorbent assay
(ELISA)-based chemiluminescent NF-kB Binding Assay Kit
(Active Motif, CA, USA) in accordance with the manufacturer’s
instructions.
LRP16 expression in primary tumor tissues was determined by
immunohistochemistry (IHC) as described previously [32].
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Statistical analyses were performed using SPSS 13.0 for
Windows (SPSS Inc, Chicago, Illinois). Paired Student’s t-tests or
two-way ANOVA followed by the student-Newman-Keuls test
were used, where applicable, to assess significant differences
between groups. To compare NF-kB DNA binding activity
between the LRP16 positive group and LRP16 negative group,
a t-test was used. Spearman’s correction test was performed to
determine the relationship between the level of expression of
LRP16 and the DNA binding activity of NF-kB. P,0.05 was
considered to be statistically significant.
Supporting Information
Figure S1 LRP16 and NF-kB p65 colocalizes in the
nuclei of 293T cells in response to TNF-a stimulation.
(A–C) 293T cells were transfected with the indicated siRNAs.
Forty-eight hours after transfection, cells were stimulated with
10 ng/ml TNF-a for 1 h, and stained with anti-LRP16 and anti-
p65 primary antibodies followed by FITC-conjugated goat anti-
mouse IgG and Alexa-Fluor 594 goat anti-rabbit IgG. The nucleus
was counterstained with DAPI. Bar=20 mm.
(PDF)
Figure S2 Ectopic expression of LRP16 markedly upre-
gulates TNF-a-induced kB-luc activity. (A, B) MCF-7 and
HeLa cells were cotransfected with 36kB-luc and the indicated
vectors. Forty-two hours after transfection, cells were simulated
with 10 ng/ml TNF-a for 7 h before luciferase assays were
performed. The relative levels of luciferase activity were normalized
to the activity obtained after cotransfection of 36kB-luc
and the empty expression vector, which was arbitrarily assigned a
value of 1. All experiments were performed in triplicate and were
repeated at least three times, and the results are expressed as
means6SD. *P,0.05.
(PDF)
Figure S3 Ectopic expression of LRP16 markedly upre-
gulates the GAL4BD-p65 induction of GAL4-luc activity.
Gal4-luc was cotransfected into 293T cells with the indicated
vectors. pRL-SV40 was used as transfection control. Forty-two
hours after transfection, cells were lysed for luciferase assays. The
relative levels of luciferase activity were normalized to the activity
obtained after cotransfection of GAL4-luc and the empty
expression vector, which was arbitrarily assigned a value of 1.
Data represent means 6 SD (error bars) of at least three
independent experiments. *P,0.05.
(PDF)
Figure S4 Knockdown of LRP16 markedly attenuates
NF-kB transcriptional activity. (A, B) MCF-7 and HeLa cells
were cotransfected with 36kB-luc, siRNA and vectors as
indicated. Forty-two hours after transfection, cells were stimulated
with 10 ng/ml TNF-a for 7 h and then luciferase assays were
performed. The relative levels of luciferase activity were normalized
to the activity obtained after cotransfection of 36kB-luc and the
empty expression vector, which wasarbitrarily assigned a value of 1.
All experiments were performed in triplicate and were repeated at
least three times, and the results are expressed as means6SD.
(PDF)
Figure S5 Knockdown of endogenous LRP16 expression
in 293T cells does not affect TNF-a-stimulated IKK
activity and nuclear translocation of NF-kB. (A) 293T cells
were transfected with the indicated siRNAs. Forty-eight hours
after transfection, cells were treated with 10 ng/ml TNF-a for
15 min, and lysed for IKK activity analysis. (B) 293T cells were
transfected with the indicated siRNAs, treated with TNF-a for the
indicated time points, lysed and the lysates were subjected to
immunoblotting with the indicated antibodies. (C) 293T cells were
transfected with the indicated siRNAs, treated with TNF-a for the
indicated time points, nuclear extracts were used for immuno-
blotting analysis with the indicated antibodies.
(PDF)
Figure S6 Ectopic expression of LRP16 or LRP16
mutants do not significantly promote TNF-a-induced
cell apoptosis. (A, B) 293T and HeLa cells that had been
transfected stably with LRP16 or the indicated LRP16 mutants
were treated with TNF-a plus CHX or left untreated for 22 h.
Annexin V assays were performed to monitor cell apoptosis.
(PDF)
Figure S7 Knockdown of LRP16 sensitizes TNF-a-in-
duced cell apoptosis. HeLa cells were transfected with the
indicated siRNAs. Forty-eight hours later, cells were treated with
TNF-a plus CHX or left untreated for 22 h. The percentage of
apoptotic cells was monitored by annexin V staining followed by
FACS analysis. Experiments to analyze apoptosis were performed
in triplicate and were repeated at least three times, and the results
are expressed as means6SD.
(PDF)
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